NCT04954040: Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19
- State
- State not given
- Phase
- Phase 2
- People
- 132 planned
- Started
- 10 Feb 2021
- Primary completion
- Oct 2021
- Arms
- Hydroxychloroquine + Azithromycin
- Results
- None posted
- 10 Feb 2021: Trial started
- 8 Jul 2021: Trial registered